Gender-specific association of methylenetetrahydrofolate reductase genotype and haplotype with the aggressiveness and prognosis of clear cell renal cell carcinoma in Japanese patients

BJU International

Volumn 106, Issue 3, 2010, Pages 424-430

  Sakano, Shigeru ^a   Hinoda, Yuji ^a   Okayama, Naoko ^a   Kawai, Yoshihisa ^a   Ito, Hideaki ^a   Nagao, Kazuhiro ^a   Hara, Takahiko ^a   Matsuyama, Hideyasu ^a  

^a YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Folate; Gender; Genetic polymorphism; Renal cell carcinoma; Survival

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2);

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER GROWTH; CLEAR CELL CARCINOMA; CLINICAL FEATURE; COMPUTER PROGRAM; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HISTOPATHOLOGY; HUMAN; JAPANESE; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; SEX RATIO; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; FEMALE; GENOTYPE; HAPLOTYPES; HUMANS; JAPAN; KIDNEY NEOPLASMS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; POLYMORPHISM, GENETIC; PROGNOSIS; SEX FACTORS;

EID: 77955738863     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2009.09107.x     Document Type: Article

References (30)

1. Jemal A, Siegel R, Ward E et al. Cancer statistics, 2008. CA Cancer J Clin 2008 58 : 71 96
2. Cohen HT, McGovern FJ. Renal-cell carcinoma. N Engl J Med 2005 353 : 2477 2490
3. Park WH, Eisen T. Prognostic factors in renal cell cancer. BJU Int 2007 99 : 1277 1281
4. Kaelin WG Jr. The von Hippel-Lindau tumor suppressor protein and clear cell renal carcinoma. Clin Cancer Res 2007 13 : 680s 684s
5. Cicek MS, Nock NL, Li L, Conti DV, Casey G, Witte JS. Relationship between methylenetetrahydrofolate reductase C677T and A1298C genotypes and haplotypes and prostate cancer risk and aggressiveness. Cancer Epidemiol Biomarkers Prev 2004 13 : 1331 1336
6. Stern LL, Mason JB, Selhub J, Choi SW. Genomic DNA hypomethylation, a characteristic of most cancers, is present in peripheral leukocytes of individuals who are homozygous for the C677T polymorphism in the methylenetetrahydrofolate reductase gene. Cancer Epidemiol Biomarkers Prev 2000 9 : 849 853
7. Friso S, Choi SW, Girelli D et al. A common mutation in the 5,10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status. Proc Natl Acad Sci USA 2002 99 : 5606 5611
8. Moore LE, Hung R, Karami S et al. Folate metabolism genes, vegetable intake and renal cancer risk in central Europe. Int J Cancer 2008 122 : 1710 1715
9. Frosst P, Blom HJ, Milos R et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995 10 : 111 113
10. Weisberg I, Tran P, Christensen B, Sibani S, Rozen R. A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab 1998 64 : 169 172
11. Dong LM, Potter JD, White E, Ulrich CM, Cardon LR, Peters U. Genetic susceptibility to cancer: the role of polymorphisms in candidate genes. JAMA 2008 299 : 2423 2436
12. Matakidou A, El Galta R, Rudd MF et al. Prognostic significance of folate metabolism polymorphisms for lung cancer. Br J Cancer 2007 97 : 247 252
13. Xu X, Gammon MD, Wetmur JG et al. B-vitamin intake, one-carbon metabolism, and survival in a population-based study of women with breast cancer. Cancer Epidemiol Biomarkers Prev 2008 17 : 2109 2116
14. Zhang W, Press OA, Haiman CA et al. Association of methylenetetrahydrofolate reductase gene polymorphisms and sex-specific survival in patients with metastatic colon cancer. J Clin Oncol 2007 25 : 3726 3731
15. Nuckel H, Frey UH, Durig J, Duhrsen U, Siffert W. Methylenetetrahydrofolate reductase (MTHFR) gene 677C T and 1298A C polymorphisms are associated with differential apoptosis of leukemic B cells in vitro and disease progression in chronic lymphocytic leukemia. Leukemia 2004 18 : 1816 1823
16. Sohn KJ, Jang H, Campan M et al. The methylenetetrahydrofolate reductase C677T mutation induces cell-specific changes in genomic DNA methylation and uracil misincorporation: a possible molecular basis for the site-specific cancer risk modification. Int J Cancer 2009 124 : 1999 2005
17. Korenaga Y, Naito K, Okayama N et al. Association of the BCRP C421A polymorphism with nonpapillary renal cell carcinoma. Int J Cancer 2005 117 : 431 434
18. Wacholder S, Chanock S, Garcia- Closas M, El Ghormli L, Rothman N. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst 2004 96 : 434 442
19. Heijmans BT, Boer JM, Suchiman HE et al. A common variant of the methylenetetrahydrofolate reductase gene (1p36) is associated with an increased risk of cancer. Cancer Res 2003 63 : 1249 1253
20. Sharp L, Little J. Polymorphisms in genes involved in folate metabolism and colorectal neoplasia: a HuGE review. Am J Epidemiol 2004 159 : 423 443
21. Dhote R, Thiounn N, Debre B, Vidal-Trecan G. Risk factors for adult renal cell carcinoma. Urol Clin North Am 2004 31 : 237 247
22. Hsu CC, Chow WH, Boffetta P et al. Dietary risk factors for kidney cancer in Eastern and Central Europe. Am J Epidemiol 2007 166 : 62 70
23. Curtin K, Bigler J, Slattery ML, Caan B, Potter JD, Ulrich CM. MTHFR C677T and A1298C polymorphisms: diet, estrogen, and risk of colon cancer. Cancer Epidemiol Biomarkers Prev 2004 13 : 285 292
24. Shi Q, Zhang Z, Li G et al. Sex differences in risk of lung cancer associated with methylene-tetrahydrofolate reductase polymorphisms. Cancer Epidemiol Biomarkers Prev 2005 14 : 1477 1484
25. Sarter B, Long TI, Tsong WH, Koh WP, Yu MC, Laird PW. Sex differential in methylation patterns of selected genes in Singapore Chinese. Hum Genet 2005 117 : 402 403
26. Loktionov A. Common gene polymorphisms, cancer progression and prognosis. Cancer Lett 2004 208 : 1 33
27. Hunter K. Host genetics influence tumour metastasis. Nat Rev Cancer 2006 6 : 141 146
28. Kawai Y, Sakano S, Korenaga Y, Eguchi S, Naito K. Associations of single nucleotide polymorphisms in the vascular endothelial growth factor gene with the characteristics and prognosis of renal cell carcinomas. Eur Urol 2007 52 : 1147 1155
29. Sakano S, Hinoda Y, Okayama N et al. The association of DNA repair gene polymorphisms with the development and progression of renal cell carcinoma. Ann Oncol 2007 18 : 1817 1827
30. Ji J, Forsti A, Sundquist J, Lenner P, Hemminki K. Survival in bladder and renal cell cancers is familial. J Am Soc Nephrol 2008 19 : 985 991